Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure
Go back to Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1179.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1179.27 | 52 Week High | $88.16 | |||
| Open | $1179.27 | 52 Week Low | $67.88 | |||
| Day High | $1179.27 | P/E | 272.98 | |||
| Day Low | $1179.27 | EPS | $4.32 | |||
| Volume | 763 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 746.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $746.54 | 52 Week High | $592.36 | |||
| Open | $746.54 | 52 Week Low | $325.35 | |||
| Day High | $746.54 | P/E | 195.94 | |||
| Day Low | $746.54 | EPS | $3.81 | |||
| Volume | 20 | |||||



